Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Non-cash Items (2019 - 2025)

Lipocine's Non-cash Items history spans 7 years, with the latest figure at $262754.0 for Q3 2025.

  • For Q3 2025, Non-cash Items rose 17.08% year-over-year to $262754.0; the TTM value through Sep 2025 reached $262754.0, up 17.08%, while the annual FY2024 figure was $29299.0, 84.92% down from the prior year.
  • Non-cash Items reached $262754.0 in Q3 2025 per LPCN's latest filing, up from $256738.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $2.9 million in Q4 2022 to a low of $4586.0 in Q2 2023.
  • Average Non-cash Items over 5 years is $984771.3, with a median of $262754.0 recorded in 2025.
  • Peak YoY movement for Non-cash Items: soared 17077.12% in 2021, then plummeted 99.83% in 2023.
  • A 5-year view of Non-cash Items shows it stood at $315330.0 in 2021, then surged by 822.69% to $2.9 million in 2022, then tumbled by 93.32% to $194228.0 in 2023, then crashed by 84.92% to $29299.0 in 2024, then skyrocketed by 796.8% to $262754.0 in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Non-cash Items are $262754.0 (Q3 2025), $256738.0 (Q2 2025), and $244926.0 (Q1 2025).